Stanton Glantz, PhD's blog

More evidence of immediate drops in heart attack DEATHS following smokefree laws

 Bianca Cox  and colleagues just published a nicely done paper, “Impact of stepwise introduction of smoke-free legislation on population rates of acute myocardial infarction deaths in Flanders, Belgium,” that shows that, after controlling for time trends, seasons, air pollution, and other factors, there were big drops in heart attack mortality immediately after smokefree laws were implemented.
 
Here is the abstract:
  Read more »

Indoor air expert publishes risk assessment of e-cigarettes

In the June 2014 issue of ASHRAE Journal, Bud Offerman, an expert on indoor air published a well-done risk assessment of active and passive exposure to e-cigarette aerosol using standard methods.  (ASHRAE is the American Society for Heating, Refrigeration, and Air Conditioning Engineering, the organization that develops engineering standards for, among other things, building ventilation systems.  The tobacco companies spent years keeping ASHR Read more »

Senators and Respresentatives criticize FDA and OMB for cost-benefit analysis that undermines public health

Members of the US Senate and House of Representatives sent a strongly worded letter to the FDA and Office of Management and Budget last week criticising the agencies for grossly understating the benefits of tobacco regulation, then discounting these understanded benefits because of lost "consumer surplus," i.e., the lost pleasure due to no longer smoking.
  Read more »

Doonesbury figured out that big tobacco would benefit from OIRA's cost-benefit models 19 years ago


Submitted to FDA:
 
Docket No. FDA-2014-N-0189
 
August 8, 2014
 
FDA and OMB should put the public health first, as the law directs them to.
 
Stanton A. Glantz, PhD
Professor and Director
 
The tracking number is 1jy-8dof-xl8c.
  Read more »

FDA Should Prohibit Flavors in all Tobacco Products including Electronic Cigarettes (new evidence)

FDA Should Prohibit Flavors in all Tobacco Products including Electronic Cigarettes
 
Docket No. FDA-2014-N-0189
Emily Anne McDonald, PhD
Lauren K. Lempert, JD
Ganna Kostygina, PhD MPH
Pamela M. Ling, MPH, MD
 
Center for Tobacco Control Research and Education
University of California San Francisco
  Read more »

Members of Congress Urge FDA to act within one year to clamp down of ecigarette marketing

You can read the letter here.  These are the people who wrote the law and know what the FDA could do if it wanted to and the While House let them.

Recent Research, some conducted by the FDA, Reinforces Need for Regulation of ALL Tobacco Products to Protect Health

Recent Research, some conducted by the FDA, Reinforces Need for Regulation of ALL Tobacco Products to Protect Health
 
Docket No. FDA-2014-N-0189
LM Dutra, ScD1; RA SA Glantz, PhD1
 
1 Center for Tobacco Control Research and Education
University of California San Francisco
 
August 1, 2014
  Read more »

Top economists say FDA Dramatically Underestimated the Net Benefits of Graphic Warning Labels on Cigarette Packaging

Today a group of leading economists released a report that is sharply critical of the way that the FDA (and, by implication, the OMB) does cost-benefit analysis of tobacco regulations, in particular saying that the consumer surplus discount the FDA/OMB applies to health benefits of regulation is simply wrong.  It is espcially significant that one of the authors of the analysis if Jonathan Gruber, whose work the FDA cites to justify applying the consumer surplus discount discount.  The economists also take FDA to task for grossly understimating the benefits of reducing tobacco use. Read more »

Excellent story in Sacrameto Bee on resergence of tobacco money to Dems in California government

Check it out at http://www.sacbee.com/2014/08/02/6601133/california-democrats-accepting....
 
We are back to the bad old days of tobacco industry dominance in state politics (together with all the old excuses) and need to raise a fuss about it.

Pro Publica publishes a great story on OMB OIRA, the part of the White House that has been blocking and watering down FDA

The story, "Lobbyists Bidding to Block Government Regs Set Sights on Secretive White House Office:When Washington lobbyists fail to derail regulations proposed by federal agencies, they often find a receptive ear within the Office of Information and Regulatory Affairs, an arm of the White House Office of Management and Budget that conducts much of its business in secret," is not about FDA, but shows how Obama, like his predicessors since Reagan are using OIRA to brock health and safety regulations.
 
So much for "independent" agencies.
  Read more »

Syndicate content